Product Description
Precision medicine (PM) is a medical model that proposes the customization of healthcare, with medical decisions, treatments, practices, or products being tailored to the individual patient. In this model, diagnostic testing is often employed for selecting appropriate and optimal therapies based on the context of a patient’s genetic content or other molecular or cellular analysis. Tools employed in precision medicine can include molecular diagnostics, imaging, and analytics.
The Precision Medicine Software market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031.
Considering the influence of COVID-19 on the global Precision Medicine Software market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.
This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.
Under COVID-19 Outbreak, how the Precision Medicine Software Industry will develop is also analyzed in detail in Chapter 1.8 of this report.
Major Players in Precision Medicine Software market are:
Flatiron Health, Inc
Pfizer, Inc
Translational Software, Inc
GlaxoSmithKline plc
Allscripts
N-of-One, Inc
SOPHiA GENETICS SA
Merck & Co., Inc
Gene42, Inc
Roper Technologies
Sunquest Information Systems Inc
PierianDx, Inc
LifeOmic Health, LLC
Qiagen
Sanofi S.A
Syapse, Inc
NantHealth, Inc
2bPrecise LLC
AstraZeneca plc
Abbott Laboratories
Koninklijke Philips N.V
Fabric Genomics
Human Longevity, Inc
IBM Watson Group
Foundation Medicine, Inc
Tempus Labs, Inc
Most important types of Precision Medicine Software products covered in this report are:
Cloud-based
On-premise
Most widely used downstream fields of Precision Medicine Software market covered in this report are:
Healthcare Providers
Research Centers & Government Institutes
Pharmaceutical & Biotechnology Companies
Others
Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others
In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.
In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.
In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.